发明授权
- 专利标题: Identification of specialty drugs
- 专利标题(中): 鉴定特种药物
-
申请号: US12011621申请日: 2008-01-28
-
公开(公告)号: US08050940B2公开(公告)日: 2011-11-01
- 发明人: Edmond Weisbart , Andrew Behm , Aimee Tharaldson , Steven Miller
- 申请人: Edmond Weisbart , Andrew Behm , Aimee Tharaldson , Steven Miller
- 申请人地址: US MO St. Louis
- 专利权人: Express Scripts, Inc.
- 当前专利权人: Express Scripts, Inc.
- 当前专利权人地址: US MO St. Louis
- 代理机构: Bryan Cave LLP
- 主分类号: G06Q10/00
- IPC分类号: G06Q10/00
摘要:
Methods for determining whether a drug is a specialty drug, methods for creating tools to be used in making the determination, and the tools themselves are disclosed. The overall value of a drug depends on the drug's attribute values with respect to each of a set of drug attributes (concerning, e.g., the drug's route of administration, targeted disease, possible adverse reactions, risk of toxicity, cost, need for patient compliance with the treatment regime, and handling, preparation, and/or storage requirements. If the overall value or its partial overall values meet certain criteria, the drug is deemed to be a specialty drug.
公开/授权文献
- US20090192807A1 Identification of specialty drugs 公开/授权日:2009-07-30
信息查询